View ValuationS.C. Helios 将来の成長Future 基準チェック /06現在、 S.C. Heliosの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Basic Materials 収益成長17.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • Apr 09No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Mar 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Mar 06S.C. Helios S.A., Annual General Meeting, Apr 06, 2026S.C. Helios S.A., Annual General Meeting, Apr 06, 2026.Board Change • Jan 22No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON23.60, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 15x in the Basic Materials industry in Europe. Total returns to shareholders of 18% over the past year.分析記事 • Nov 21Even With A 33% Surge, Cautious Investors Are Not Rewarding S.C. Helios S.A.'s (BVB:HEAL) Performance CompletelyS.C. Helios S.A. ( BVB:HEAL ) shareholders have had their patience rewarded with a 33% share price jump in the last...分析記事 • Nov 12We Like These Underlying Return On Capital Trends At S.C. Helios (BVB:HEAL)There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Valuation Update With 7 Day Price Move • Oct 29Investor sentiment improves as stock rises 27%After last week's 27% share price gain to RON21.00, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 15x in the Basic Materials industry in Europe.分析記事 • Oct 07S.C. Helios S.A.'s (BVB:HEAL) Price Is Right But Growth Is Lacking After Shares Rocket 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...分析記事 • Oct 07S.C. Helios S.A. (BVB:HEAL) Held Back By Insufficient Growth Even After Shares Climb 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improves as stock rises 23%After last week's 23% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 16x in the Basic Materials industry in Europe.分析記事 • Jun 12S.C. Helios (BVB:HEAL) Is Experiencing Growth In Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Board Change • May 08No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Apr 26Further Upside For S.C. Helios S.A. (BVB:HEAL) Shares Could Introduce Price Risks After 29% BounceThose holding S.C. Helios S.A. ( BVB:HEAL ) shares would be relieved that the share price has rebounded 29% in the last...分析記事 • Apr 21S.C. Helios (BVB:HEAL) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 25%After last week's 25% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 17x in the Basic Materials industry in Romania. Total returns to shareholders of 122% over the past year.New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Market cap is less than US$10m (RON23.6m market cap, or US$5.16m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).お知らせ • Mar 08S.C. Helios S.A., Annual General Meeting, Apr 08, 2025S.C. Helios S.A., Annual General Meeting, Apr 08, 2025.分析記事 • Feb 25Take Care Before Jumping Onto S.C. Helios S.A. (BVB:HEAL) Even Though It's 25% CheaperThe S.C. Helios S.A. ( BVB:HEAL ) share price has fared very poorly over the last month, falling by a substantial 25...Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to RON21.60, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 47x in the Basic Materials industry in Romania. Total returns to shareholders of 167% over the past year.分析記事 • Dec 30S.C. Helios S.A. (BVB:HEAL) Stock Rockets 29% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...Valuation Update With 7 Day Price Move • Dec 06Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 48x in the Basic Materials industry in Romania.Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to RON19.00, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 19x in the Basic Materials industry in Romania.分析記事 • Nov 10S.C. Helios S.A. (BVB:HEAL) Stock Rockets 192% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 40%After last week's 40% share price gain to RON12.50, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 19x in the Basic Materials industry in Romania.分析記事 • Nov 03S.C. Helios (BVB:HEAL) Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Board Change • Oct 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Sep 03A Piece Of The Puzzle Missing From S.C. Helios S.A.'s (BVB:HEAL) Share PriceWith a price-to-earnings (or "P/E") ratio of 4.8x S.C. Helios S.A. ( BVB:HEAL ) may be sending very bullish signals at...Board Change • Aug 30No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON8.95, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 24x in the Basic Materials industry in Romania.分析記事 • May 21Not Many Are Piling Into S.C. Helios S.A. (BVB:HEAL) Stock Yet As It Plummets 27%S.C. Helios S.A. ( BVB:HEAL ) shareholders that were waiting for something to happen have been dealt a blow with a 27...Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 27%After last week's 27% share price decline to RON6.50, the stock trades at a trailing P/E ratio of 3.5x. Average trailing P/E is 10x in the Basic Materials industry in Romania. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、S.C. Helios は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BVB:HEAL - アナリストの将来予測と過去の財務データ ( )RON Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2025326N/AN/AN/A9/30/2025325N/AN/AN/A6/30/2025325N/AN/AN/A3/31/2025335N/AN/AN/A1/1/202534566N/A10/1/2024345N/AN/AN/A6/30/2024354N/AN/AN/A3/31/2024353N/AN/AN/A1/1/202435355N/A10/1/2023363N/AN/AN/A6/30/2023372N/AN/AN/A3/31/2023373N/AN/AN/A1/1/202338377N/A9/30/2022353N/AN/AN/A6/30/2022323N/AN/AN/A3/31/2022303N/AN/AN/A1/1/202229322N/A10/1/2021303N/AN/AN/A6/30/2021312N/AN/AN/A3/31/2021292N/AN/AN/A1/1/202128266N/A10/1/2020262N/AN/AN/A6/30/2020241N/AN/AN/A3/31/2020241N/AN/AN/A1/1/202025233N/A10/1/2019252N/AN/AN/A6/30/2019251N/AN/AN/A3/31/2019251N/AN/AN/A12/31/2018251N/A1N/A9/30/2018261N/AN/AN/A6/30/2018281N/AN/AN/A3/31/2018281N/AN/AN/A1/1/2018281N/A7N/A10/1/2017271N/AN/AN/A6/30/2017261N/AN/AN/A3/31/2017261N/AN/AN/A1/1/2017251N/A3N/A10/1/2016251N/AN/AN/A6/30/2016241N/AN/AN/A3/31/2016251N/AN/AN/A1/1/2016251N/A4N/A10/1/2015251N/AN/AN/A6/30/2015241N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: HEALの予測収益成長が 貯蓄率 ( 6.8% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: HEALの収益がRO市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: HEALの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: HEALの収益がRO市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: HEALの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: HEALの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 15:03終値2026/04/24 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋S.C. Helios S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • Apr 09No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Mar 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Mar 06S.C. Helios S.A., Annual General Meeting, Apr 06, 2026S.C. Helios S.A., Annual General Meeting, Apr 06, 2026.
Board Change • Jan 22No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON23.60, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 15x in the Basic Materials industry in Europe. Total returns to shareholders of 18% over the past year.
分析記事 • Nov 21Even With A 33% Surge, Cautious Investors Are Not Rewarding S.C. Helios S.A.'s (BVB:HEAL) Performance CompletelyS.C. Helios S.A. ( BVB:HEAL ) shareholders have had their patience rewarded with a 33% share price jump in the last...
分析記事 • Nov 12We Like These Underlying Return On Capital Trends At S.C. Helios (BVB:HEAL)There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Valuation Update With 7 Day Price Move • Oct 29Investor sentiment improves as stock rises 27%After last week's 27% share price gain to RON21.00, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 15x in the Basic Materials industry in Europe.
分析記事 • Oct 07S.C. Helios S.A.'s (BVB:HEAL) Price Is Right But Growth Is Lacking After Shares Rocket 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
分析記事 • Oct 07S.C. Helios S.A. (BVB:HEAL) Held Back By Insufficient Growth Even After Shares Climb 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improves as stock rises 23%After last week's 23% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 16x in the Basic Materials industry in Europe.
分析記事 • Jun 12S.C. Helios (BVB:HEAL) Is Experiencing Growth In Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Board Change • May 08No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Apr 26Further Upside For S.C. Helios S.A. (BVB:HEAL) Shares Could Introduce Price Risks After 29% BounceThose holding S.C. Helios S.A. ( BVB:HEAL ) shares would be relieved that the share price has rebounded 29% in the last...
分析記事 • Apr 21S.C. Helios (BVB:HEAL) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 25%After last week's 25% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 17x in the Basic Materials industry in Romania. Total returns to shareholders of 122% over the past year.
New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Market cap is less than US$10m (RON23.6m market cap, or US$5.16m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
お知らせ • Mar 08S.C. Helios S.A., Annual General Meeting, Apr 08, 2025S.C. Helios S.A., Annual General Meeting, Apr 08, 2025.
分析記事 • Feb 25Take Care Before Jumping Onto S.C. Helios S.A. (BVB:HEAL) Even Though It's 25% CheaperThe S.C. Helios S.A. ( BVB:HEAL ) share price has fared very poorly over the last month, falling by a substantial 25...
Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to RON21.60, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 47x in the Basic Materials industry in Romania. Total returns to shareholders of 167% over the past year.
分析記事 • Dec 30S.C. Helios S.A. (BVB:HEAL) Stock Rockets 29% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...
Valuation Update With 7 Day Price Move • Dec 06Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 48x in the Basic Materials industry in Romania.
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to RON19.00, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 19x in the Basic Materials industry in Romania.
分析記事 • Nov 10S.C. Helios S.A. (BVB:HEAL) Stock Rockets 192% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 40%After last week's 40% share price gain to RON12.50, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 19x in the Basic Materials industry in Romania.
分析記事 • Nov 03S.C. Helios (BVB:HEAL) Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Board Change • Oct 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Sep 03A Piece Of The Puzzle Missing From S.C. Helios S.A.'s (BVB:HEAL) Share PriceWith a price-to-earnings (or "P/E") ratio of 4.8x S.C. Helios S.A. ( BVB:HEAL ) may be sending very bullish signals at...
Board Change • Aug 30No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON8.95, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 24x in the Basic Materials industry in Romania.
分析記事 • May 21Not Many Are Piling Into S.C. Helios S.A. (BVB:HEAL) Stock Yet As It Plummets 27%S.C. Helios S.A. ( BVB:HEAL ) shareholders that were waiting for something to happen have been dealt a blow with a 27...
Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 27%After last week's 27% share price decline to RON6.50, the stock trades at a trailing P/E ratio of 3.5x. Average trailing P/E is 10x in the Basic Materials industry in Romania.